Bank of America
OKUR

Bank of America’s OnKure Therapeutics OKUR Stock Holding History

Bank of America’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-141
Closed -$409 – 7094
2025
Q4 		$409 Sell
141
-755
-84% -$2.26K ﹤0.01% 6590
2025
Q3 		$2.46K Buy
896
+48
+6% +$119 ﹤0.01% 7377
2025
Q2 		$2.03K Buy
848
+627
+284% +$1.64K ﹤0.01% 7433
2025
Q1 		$950 Sell
221
-249,421
-100% -$1.4M ﹤0.01% 7433
2024
Q4 		$2.15M Buy
249,642
+249,521
+206,216% +$3.78M ﹤0.01% 4381
2024
Q3 		$2.06K Buy
121
+26
+27% +$385 ﹤0.01% 7126
2024
Q2 		$1.43K Sell
95
-342
-78% -$5.8K ﹤0.01% 7185
2024
Q1 		$7.26K Sell
437
-1,961
-82% -$32.4K ﹤0.01% 6946
2023
Q4 		$38.4K Sell
2,398
-1,759
-42% -$110K ﹤0.01% 6667
2023
Q3 		$317K Buy
4,157
+3,558
+594% +$242K ﹤0.01% 5629
2023
Q2 		$39.3K Buy
599
+512
+589% +$41.2K ﹤0.01% 6536
2023
Q1 		$5.17K Buy
87
+29
+50% +$1.05K ﹤0.01% 7063
2022
Q4 		$1.34K Sell
58
-1,698
-97% -$45K ﹤0.01% 7298
2022
Q3 		$59K Sell
1,756
-492
-22% -$16.2K ﹤0.01% 6602
2022
Q2 		$60K Sell
2,248
-1,840
-45% -$42.8K ﹤0.01% 6746
2022
Q1 		$121K Buy
4,088
+792
+24% +$44.3K ﹤0.01% 6761
2021
Q4 		$282K Buy
3,296
+1,509
+84% +$111K ﹤0.01% 6289
2021
Q3 		$133K Buy
1,787
+1,554
+667% +$132K ﹤0.01% 6562
2021
Q2 		$22K Buy
+233
New +$26K ﹤0.01% 7112

Other funds holding OKUR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Bank of America's OKUR Position: Q1 2026 in Review

Bank of America sold out of OnKure Therapeutics (OKUR) in Q1 2026, closing a stake of 141 shares — an estimated $409 sold.

Bank of America first reported a position in OKUR in Q2 2021 and held it in 19 quarters. The position peaked at $2.15M in Q4 2024. 51 funds tracked by Wall St. Rank hold OKUR as of Q1 2026.

  • Bank of America reported no remaining OnKure Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 141 OnKure Therapeutics shares in Q1 2026, an estimated $409.
  • Bank of America first reported a position in OnKure Therapeutics in Q2 2021 and held it in 19 quarters.
  • Bank of America's OnKure Therapeutics position peaked at $2.15M in Q4 2024.
  • 51 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.